Refine
Has Fulltext
- no (15)
Year of publication
Document Type
- Article (15) (remove)
Language
- English (15)
Is part of the Bibliography
- yes (15)
Keywords
- Fluorescence lifetime imaging microscopy (2)
- polyglycerol (2)
- Atopic dermatitis (1)
- Biocompatibility (1)
- CMS (1)
- Cellular uptake (1)
- Core-multishell nanocarriers (1)
- Cu NP-incorporated MI-dPG coating (1)
- Dendritic cells (1)
- Dendritic core-multishell nanocarriers (1)
- Dermal delivery (1)
- Dermal drug delivery (1)
- Dexamethasone (1)
- Drug delivery (1)
- High resolution microscopy (1)
- Inflammatory skin disease (1)
- Langerhans cells (1)
- Multi-domain nanoparticles (1)
- Nanomaterials (1)
- Nanoparticle uptake (1)
- Nanoparticles (1)
- Nanotoxicology (1)
- Oxazolone (1)
- Penetration enhancement (1)
- Skin (1)
- Skin model (1)
- Skin penetration (1)
- Topical treatment (1)
- amperometry (1)
- antibacterial effect (1)
- biosensors (1)
- cancer stem cells (1)
- click chemistry (1)
- dendritic (1)
- dendritic polyglycerol (1)
- density functional calculations (1)
- drug-resistant bacteria (1)
- gold nanostars (1)
- hemocompatibility (1)
- heparan sulfate (1)
- herpes simplex virus (1)
- hydrogel (1)
- imines (1)
- in situ chemical reduction (1)
- isomerization (1)
- multivalent (1)
- nanoparticles (1)
- photochemistry (1)
- photothermal therapy (1)
- poly(ethylene glycol) (1)
- polyimides (1)
- retinoic acid (1)
- surface chemistry (1)
- thermochemistry (1)
- universal coating (1)
The existence of cancer stem cells (CSCs) poses a major obstacle for the success of current cancer therapies, especially the fact that non-CSCs can spontaneously turn into CSCs, which lead to the failure of the treatment and tumor relapse. Therefore, it is very important to develop effective strategies for the eradication of the CSCs. In this work, we have developed a CSCs-specific targeted, retinoic acid (RA)-loaded gold nanostars-dendritic polyglycerol (GNSs-dPG) nanoplatform for the efficient eradication of CSCs. The nanocomposites possess good biocompatibility and exhibit effective CSCs-specific multivalent targeted capability due to hyaluronic acid (HA) decorated on the multiple attachment sites of the bioinert dendritic polyglycerol (dPG). With the help of CSCs differentiation induced by RA, the self-renewal of breast CSCs and tumor growth were suppressed by the high therapeutic efficacy of photothermal therapy (PTT) in a synergistic inhibitory manner. Moreover, the stemness gene expression and CSC-driven tumorsphere formation were significantly diminished. In addition, the in vivo tumor growth and CSCs were also effectively eliminated, which indicated superior anticancer activity, effective CSCs suppression, and prevention of relapse. Taken together, we developed a CSCs-specific targeted, RA-loaded GNSs-dPG nanoplatform for the targeted eradication of CSCs and for preventing the relapse.